ULS · UL Solutions Inc.
Price & Indicators
Up next
AI Brief
TL;DR.
AI-generated from the earnings call and 8-K · may contain errors · not investment advice
Ask ALVIS about this →Equibles Rating
blended score · not investment adviceBlended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Guidance & track record
Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.
Technicals
trend & momentum for long-term holders SellIllustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
the company's own KPIs, from written earnings releases and filings| Metric | Latest | Period | YoY |
|---|---|---|---|
| Adjusted Diluted Earnings Per Share non-GAAP | $1.09 | Six Months Ended June 30 | — |
|
|
|||
| Adjusted EBITDA non-GAAP | 416M | Six Months Ended June 30 | — |
|
|
|||
| Adjusted EBITDA margin non-GAAP | 26.4% | Six Months Ended June 30 | — |
|
|
|||
| Adjusted Net Income non-GAAP | 236M | Six Months Ended June 30 | — |
|
|
|||
| Adjusted Net Income margin non-GAAP | 15% | Six Months Ended June 30 | — |
|
|
|||
| Consumer Adjusted EBITDA non-GAAP | 132M | Six Months Ended June 30 | — |
|
|
|||
| Consumer Adjusted EBITDA margin non-GAAP | 19.4% | Six Months Ended June 30 | — |
|
|
|||
| Free Cash Flow non-GAAP | $241M | six months ended June 30, 2026 | — |
| Free Cash Flow margin non-GAAP | 15.3% | Six Months Ended June 30 | — |
| Industrial Adjusted EBITDA non-GAAP | 253M | Six Months Ended June 30 | — |
|
|
|||
| Industrial Adjusted EBITDA margin non-GAAP | 32.6% | Six Months Ended June 30 | — |
|
|
|||
| Organic revenue growth | 6.6% | Q2 2026 | — |
|
|
|||
| Risk & Compliance Software Adjusted EBITDA non-GAAP | 31M | Six Months Ended June 30 | — |
| Risk & Compliance Software Adjusted EBITDA margin non-GAAP | 26.5% | Six Months Ended June 30 | — |
| Organic growth | 6.2% | Full-Year 2025 | — |
Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period
Versus peers
Specialty Business Services — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
ULS
this stock
UL Solutions Inc.
|
$15.19B | -4.6% | +6.4% | 30.4 | 2.4% |
|
CTAS
Cintas Corp
|
$81.43B | +8.2% | +6.4% | — | 2.8% |
|
RELX
Relx PLC
|
$62.04B | -12.5% | — | — | 0.2% |
|
TRI
Thomson Reuters Corp /Can/
|
$45.87B | -19.7% | — | — | 3.1% |
|
CPRT
Copart Inc
|
$31.78B | -12.3% | +24.7% | 21.5 | 4.6% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionPerformance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| ULS | -2.0% | -13.1% | -10.4% | -17.9% | -4.6% |
| SPY | -2.0% | +3.3% | +11.2% | +2.1% | +11.8% |
| vs SPY | -0.1% | -16.4% | -21.5% | -20.0% | -16.4% |
Capital returns
Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.